Pliant Therapeutics's total assets for Q4 2024 were $396.95M, a decrease of -10.93% from the previous quarter. PLRX total liabilities were $92.87M for the fiscal quarter, a -6.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.